Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
33
CYCC Quote, Financials, Valuation and Earnings
Last price:
$8.26
Seasonality move
:
-9.19%
Day range:
$7.51 - $10.28
52-week range:
$3.08 - $597.60
Dividend yield:
439.02%
P/E ratio:
--
P/S ratio:
25.41x
P/B ratio:
4.24x
Volume:
3.6M
Avg. volume:
2.6M
1-year change:
-98.05%
Market cap:
$13M
Revenue:
$43K
EPS (TTM):
-$19.68
Earnings Data
Next earnings date for CYCC
Aug 14
2025
Most recent earnings per share
--
Missed by --
(May 15/2025)
Consensus Estimate
--
(May 15/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CYCC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/15/2025 | Q1 | -- | -- | -- | -- | -- |
| 03/26/2025 | Q4 | -- | -- | -$79.20 | -- | -- |
| 11/12/2024 | Q3 | $10K | $10K | -$43.20 | -$129.60 | $86.40 |
| 08/14/2024 | Q2 | $15K | $4K | -$172.80 | -$344.40 | $171.60 |
| 05/14/2024 | Q1 | -- | $29K | -$544.80 | -$1,183.20 | $638.40 |
| 03/19/2024 | Q4 | -- | $31K | -$1,495.20 | -$1,524.00 | $28.80 |
| 11/13/2023 | Q3 | -- | $16K | -$115.20 | -$1,350.00 | $1,234.80 |
| 08/10/2023 | Q2 | -- | $373K | -$1,576.80 | -$1,944.00 | $367.20 |
| 05/11/2023 | Q1 | -- | -- | -$1,680.00 | -$2,430.00 | $750.00 |
| 03/28/2023 | Q4 | -- | -- | -$2,160.00 | -$1,920.00 | -$240.00 |
| 11/10/2022 | Q3 | -- | -- | -$1,548.00 | -$1,740.00 | $192.00 |
| 08/10/2022 | Q2 | -- | -- | -$1,656.00 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$1,512.00 | -- | -- |
| 03/28/2022 | Q4 | -- | -- | -$1,944.00 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$1,944.00 | -- | -- |
| 08/11/2021 | Q2 | -- | -- | -$2,016.00 | -- | -- |
| 05/12/2021 | Q1 | -- | -- | -$1,800.00 | -- | -- |
| 02/25/2021 | Q4 | -- | -- | -$4,824.00 | -- | -- |
| 11/11/2020 | Q3 | -- | -- | -$1,692.00 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$2,088.00 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$5,336.13 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$10,080.00 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$8,197.48 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$7,701.68 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$7,949.58 | -- | -- |
| 12/31/2018 | Q4 | -- | $150K | -$11,953.76 | -- | -- |
| 11/09/2018 | Q3 | -- | -- | -$12,759.04 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$11,457.83 | -- | -- |
| 05/14/2018 | Q1 | -- | -- | -$8,427.71 | -- | -- |
| 03/28/2018 | Q4 | -- | -- | -$12,560.24 | -- | -- |
| 11/09/2017 | Q3 | -- | -- | -$65,520.00 | -- | -- |
| 08/09/2017 | Q2 | -- | -- | -$36,672.13 | -- | -- |
| 05/11/2017 | Q1 | -- | -- | -$27,360.00 | -- | -- |
| 03/28/2017 | Q4 | -- | $277K | -$49,915.25 | -- | -- |
| 11/14/2016 | Q3 | -- | $205K | -$61,920.00 | -- | -- |
| 08/10/2016 | Q2 | -- | $222K | -$73,536.59 | -- | -- |
| 05/11/2016 | Q1 | -- | $139K | -$75,390.24 | -- | -- |
| 03/24/2016 | Q4 | -- | $421K | -$86,400.35 | -- | -- |
| 11/12/2015 | Q3 | -- | $715K | -$68,975.00 | -- | -- |
Cyclacel Pharmaceuticals Earnings Questions
-
How Much did Cyclacel Pharmaceuticals Generate in Revenue Last Quarter?
Cyclacel Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Cyclacel Pharmaceuticals Beat Earnings Last Quarter?
Cyclacel Pharmaceuticals announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is Cyclacel Pharmaceuticals Profitable?
Cyclacel Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Cyclacel Pharmaceuticals EPS Next Year?
Cyclacel Pharmaceuticals's earnings are forecast to decrease from -$501.60 per share to -$1.95 per share next year representing a decrease of -92.71%.
-
When is Cyclacel Pharmaceuticals's Earnings Date?
Cyclacel Pharmaceuticals's next earnings date is August 14, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
